4D Molecular Therapeutics Cash Flow Statement 2019-2024 | FDMT

Fifteen years of historical annual cash flow statements for 4D Molecular Therapeutics (FDMT).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-100.84$-107.49$-71.32$-56.69$-49.31
$2.96$3.46$2.24$1.44$1.00
$21.46$18.68$15.48$5.05$11.33
$24.42$22.15$17.72$6.50$12.34
$0$0.05$1.44$-0.51$0.15
$0$0$0$0$0
$0.90$-1.64$2.29$0.04$0.53
$-3.64$-2.23$-19.95$-2.15$-4.26
$0.63$-1.34$-15.53$-0.71$0.26
$-75.79$-86.69$-69.13$-50.91$-36.71
$-2.77$-11.54$-9.11$-1.00$-3.20
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$118$-5.51$-163.57$0$0
$118$-5.51$-163.57$0$0
$0$0$0$0$0
$116$-17.05$-172.68$-1.00$-3.20
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$157$3.55$118$207$-2.19
$157$3.55$118$279$-2.20
$0$0$0$0$0
$0$-0.47$0$0$0
$157$3.09$118$279$-2.20
$197$-100.65$-123.73$227$-42.11
$19.67$17.12$13.80$4.98$3.54
$0$0$0$0$0